Cargando…

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran

OBJECTIVE: This study aims to assess geographic inequalities in the prevalence, awareness of diagnosis, treatment coverage and effective control of diabetes in 429 districts of Iran. METHODS: A modelling study by the small area estimation method, based on a nationwide cross-sectional survey, Iran ST...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perseh, Lida, Peimani, Maryam, Ghasemi, Erfan, Nasli-Esfahani, Ensieh, Rezaei, Negar, Farzadfar, Farshad, Larijani, Bagher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847158/ https://www.ncbi.nlm.nih.gov/pubmed/36650506 http://dx.doi.org/10.1186/s12902-023-01271-z

Ejemplares similares

Iran Diabetes Research Roadmap (IDRR): the study protocol
por: Shafiee, Gita, et al.
Publicado: (2016)

Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran
por: NASLI-ESFAHANI, Ensieh, et al.
Publicado: (2014)

National and sub-national burden and trend of type 1 diabetes in 31 provinces of Iran, 1990–2019
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

Social determinants of health inequity in Iran: a narrative review
por: Rezaei, Negar, et al.
Publicado: (2022)

Physical Activity Behavior During the COVID-19 Outbreak in Individuals with Type 2 Diabetes: Role of Social Support and Other Covariates
por: Peimani, Maryam, et al.
Publicado: (2022)

Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran
por: Nasli-Esfahani, Ensieh, et al.
Publicado: (2017)

Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran
por: Peimani, Maryam, et al.
Publicado: (2022)

Policy Implications for Diabetes Prevention and Control: An Experience from Iran
por: Peykari, Niloofar, et al.
Publicado: (2022)

National and subnational burden of stroke in Iran from 1990 to 2019
por: Fallahzadeh, Aida, et al.
Publicado: (2022)

Inequality of obesity and socioeconomic factors in Iran: a systematic review and meta- analyses
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Evidence Gap and Knowledge Map of Physical Activity Research in Diabetes in Iran: A Scoping Review
por: Sanjari, Mahnaz, et al.
Publicado: (2021)

Socioeconomic inequalities and diabetes: A systematic review from Iran
por: Peykari, Niloofar, et al.
Publicado: (2015)

A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents
por: Djalalinia, Shirin, et al.
Publicado: (2016)

Metabolic signatures of insulin resistance in non-diabetic individuals
por: Arjmand, Babak, et al.
Publicado: (2022)

Diabetes management during Ramadan amid Covid-19 pandemic
por: Tootee, Ali, et al.
Publicado: (2020)

A machine learning approach to evaluate the state of hypertension care coverage: From 2016 STEPs survey in Iran
por: Tavolinejad, Hamed, et al.
Publicado: (2022)

Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran
por: Madani, Sedigheh, et al.
Publicado: (2021)

Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021
por: Azadnajafabad, Sina, et al.
Publicado: (2023)

The levels of BMI and patterns of obesity and overweight during the COVID-19 pandemic: Experience from the Iran STEPs 2021 survey
por: Djalalinia, Shirin, et al.
Publicado: (2022)

Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019
por: Moradi, Soroush, et al.
Publicado: (2023)

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans
por: Azadnajafabad, Sina, et al.
Publicado: (2021)

Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic
por: Keykhaei, Mohammad, et al.
Publicado: (2021)

Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2023)

Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: Results from the GBD study 2019
por: Khanmohammadi, Shaghayegh, et al.
Publicado: (2023)

Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019
por: Shokri Varniab, Zahra, et al.
Publicado: (2022)

National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
por: Aryannejad, Armin, et al.
Publicado: (2023)

Correction to: National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
por: Aryannejad, Armin, et al.
Publicado: (2023)

Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households’ data
por: Mahdavi, Mahdi, et al.
Publicado: (2022)

Amino acid profiling in the gestational diabetes mellitus
por: Rahimi, Najmeh, et al.
Publicado: (2017)

Mechanisms involved in altered bone metabolism in diabetes: a narrative review
por: Ghodsi, Maryam, et al.
Publicado: (2016)

National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2022)

Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022)

Telehealth for fighting the novel coronavirus: review of activities on Diabetes and Osteoporosis management in outbreak
por: Sanjari, Mahnaz, et al.
Publicado: (2020)

Psychometric properties of the Iranian version of Diabetes Empowerment Scale (IR-DES-28)
por: Mahjouri, Mohammad Yoosef, et al.
Publicado: (2012)

Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study
por: Khosravi Shadmani, Fatemeh, et al.
Publicado: (2019)

Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up
por: Nasli-Esfahani, Ensieh, et al.
Publicado: (2015)

Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019
por: Azadnajafabad, Sina, et al.
Publicado: (2022)

A Report on Statistics of an Online Self-screening Platform for COVID-19 and Its Effectiveness in Iran
por: Azadnajafabad, Sina, et al.
Publicado: (2021)

Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells
por: Arjmand, Babak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2bpjh2ong12fdpkltt5jd721lt